ID   BRD2_HUMAN              Reviewed;         801 AA.
AC   P25440; A2AAU0; B0S7P0; B1AZT1; O00699; O00700; Q15310; Q5STC9; Q63HQ9;
AC   Q658Y7; Q6P3U2; Q969U4;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2001, sequence version 2.
DT   12-OCT-2022, entry version 212.
DE   RecName: Full=Bromodomain-containing protein 2;
DE   AltName: Full=O27.1.1;
DE   AltName: Full=Really interesting new gene 3 protein;
GN   Name=BRD2; Synonyms=KIAA9001, RING3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=T-cell;
RX   PubMed=1352711; DOI=10.3109/10425179209020804;
RA   Beck S., Hanson I., Kelly A., Pappin D.J.C., Trowsdale J.;
RT   "A homologue of the Drosophila female sterile homeotic (fsh) gene in the
RT   class II region of the human MHC.";
RL   DNA Seq. 2:203-210(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND SEQUENCE REVISION TO N-TERMINUS.
RX   PubMed=8781126; DOI=10.1007/bf02602785;
RA   Thorpe K.L., Abdulla S., Kaufman J., Trowsdale J., Beck S.;
RT   "Phylogeny and structure of the RING3 gene.";
RL   Immunogenetics 44:391-396(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RA   Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y., Sato S.,
RA   Nagase T., Seki T., Ishikawa K., Tabata S.;
RL   Submitted (JUL-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4).
RC   TISSUE=Bone marrow, and Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PHE-238.
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH HERPES VIRUS 8 PROTEIN LANA1 (MICROBIAL INFECTION).
RX   PubMed=16227282; DOI=10.1128/jvi.79.21.13618-13629.2005;
RA   Viejo-Borbolla A., Ottinger M., Bruening E., Buerger A., Koenig R.,
RA   Kati E., Sheldon J.A., Schulz T.F.;
RT   "Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's
RT   Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-
RT   1) that is required for multiple functions of LANA-1.";
RL   J. Virol. 79:13618-13629(2005).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH ACETYLATED CHROMATIN.
RX   PubMed=18406326; DOI=10.1016/j.molcel.2008.01.018;
RA   LeRoy G., Rickards B., Flint S.J.;
RT   "The double bromodomain proteins Brd2 and Brd3 couple histone acetylation
RT   to transcription.";
RL   Mol. Cell 30:51-60(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-298; SER-301; SER-305 AND
RP   SER-633, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37; SER-298 AND SER-301, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT THR-6; SER-298 AND SER-301, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-298, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-298 AND SER-633, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-298; SER-301 AND SER-305, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 73-194, HOMODIMERIZATION,
RP   INTERACTION WITH E2F1 AND HISTONE H4, AND MUTAGENESIS OF GLN-78;
RP   142-MET-GLN-143; TYR-153; ILE-154; GLU-170; LEU-174; VAL-177 AND GLN-182.
RX   PubMed=17148447; DOI=10.1074/jbc.m605971200;
RA   Nakamura Y., Umehara T., Nakano K., Jang M.K., Shirouzu M., Morita S.,
RA   Uda-Tochio H., Hamana H., Terada T., Adachi N., Matsumoto T., Tanaka A.,
RA   Horikoshi M., Ozato K., Padmanabhan B., Yokoyama S.;
RT   "Crystal structure of the human BRD2 bromodomain: insights into
RT   dimerization and recognition of acetylated histone h4.";
RL   J. Biol. Chem. 282:4193-4201(2007).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.61 ANGSTROMS) OF 344-452.
RX   PubMed=20871596; DOI=10.1038/nature09504;
RA   Filippakopoulos P., Qi J., Picaud S., Shen Y., Smith W.B., Fedorov O.,
RA   Morse E.M., Keates T., Hickman T.T., Felletar I., Philpott M., Munro S.,
RA   McKeown M.R., Wang Y., Christie A.L., West N., Cameron M.J., Schwartz B.,
RA   Heightman T.D., La Thangue N., French C.A., Wiest O., Kung A.L., Knapp S.,
RA   Bradner J.E.;
RT   "Selective inhibition of BET bromodomains.";
RL   Nature 468:1067-1073(2010).
RN   [20]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLU-30; GLY-49; SER-49; PRO-212; PHE-238;
RP   GLN-260; VAL-474; GLY-558; THR-569; PRO-599 AND LEU-714.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May play a role in spermatogenesis or folliculogenesis (By
CC       similarity). Binds hyperacetylated chromatin and plays a role in the
CC       regulation of transcription, probably by chromatin remodeling.
CC       Regulates transcription of the CCND1 gene. Plays a role in nucleosome
CC       assembly. {ECO:0000250, ECO:0000269|PubMed:18406326}.
CC   -!- SUBUNIT: Homodimer. Interacts with E2F1 and with histone H4 acetylated
CC       at 'Lys-13'. {ECO:0000269|PubMed:17148447,
CC       ECO:0000269|PubMed:18406326}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with herpes virus 8 protein
CC       LANA1. {ECO:0000269|PubMed:16227282}.
CC   -!- INTERACTION:
CC       P25440; P62805: H4C9; NbExp=5; IntAct=EBI-2874802, EBI-302023;
CC       P25440; Q13761: RUNX3; NbExp=8; IntAct=EBI-2874802, EBI-925990;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. Note=Detected on chromatin
CC       and nucleosomes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=P25440-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P25440-2; Sequence=VSP_022600;
CC       Name=3;
CC         IsoId=P25440-3; Sequence=VSP_055029;
CC       Name=4;
CC         IsoId=P25440-4; Sequence=VSP_055028;
CC   -!- DOMAIN: One bromodomain is sufficient for a partial interaction with
CC       histone H4 acetylated at 'Lys-13'.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA68890.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X62083; CAA43996.1; -; mRNA.
DR   EMBL; M80613; AAA68890.1; ALT_INIT; mRNA.
DR   EMBL; X96670; CAA65450.1; -; Genomic_DNA.
DR   EMBL; Z96104; CAC69989.1; -; Genomic_DNA.
DR   EMBL; D42040; BAA07641.1; -; mRNA.
DR   EMBL; BX647233; CAH56179.1; -; mRNA.
DR   EMBL; BX648109; CAH56171.1; -; mRNA.
DR   EMBL; AL832722; CAH56208.1; -; mRNA.
DR   EMBL; AL645941; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL662845; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL805913; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX005422; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX908719; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR936909; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL935042; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX03662.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03663.1; -; Genomic_DNA.
DR   EMBL; BC063840; AAH63840.1; -; mRNA.
DR   CCDS; CCDS4762.1; -. [P25440-1]
DR   CCDS; CCDS56420.1; -. [P25440-2]
DR   CCDS; CCDS56421.1; -. [P25440-3]
DR   PIR; A56619; A56619.
DR   RefSeq; NP_001106653.1; NM_001113182.2. [P25440-1]
DR   RefSeq; NP_001186384.1; NM_001199455.1. [P25440-2]
DR   RefSeq; NP_001186385.1; NM_001199456.1. [P25440-3]
DR   RefSeq; NP_001278915.1; NM_001291986.1. [P25440-4]
DR   RefSeq; NP_005095.1; NM_005104.3. [P25440-1]
DR   PDB; 1X0J; X-ray; 1.80 A; A/B/C=73-194.
DR   PDB; 2DVQ; X-ray; 2.04 A; A/B/C=73-194.
DR   PDB; 2DVR; X-ray; 2.30 A; A/B/C=73-194.
DR   PDB; 2DVS; X-ray; 2.04 A; A/B/C=73-194.
DR   PDB; 2DVV; X-ray; 1.80 A; A=348-455.
DR   PDB; 2E3K; X-ray; 2.30 A; A/B/C/D=348-455.
DR   PDB; 2G4A; NMR; -; A=348-455.
DR   PDB; 2YDW; X-ray; 1.90 A; A/B/C=67-200.
DR   PDB; 2YEK; X-ray; 1.98 A; A/B/C=67-200.
DR   PDB; 3AQA; X-ray; 2.30 A; A/B/C=73-194.
DR   PDB; 3ONI; X-ray; 1.61 A; A=344-455.
DR   PDB; 4A9E; X-ray; 1.91 A; A/B/C=67-200.
DR   PDB; 4A9F; X-ray; 1.73 A; A/B/C=67-200.
DR   PDB; 4A9H; X-ray; 2.05 A; A/B/C=67-200.
DR   PDB; 4A9I; X-ray; 2.25 A; A/B/C=67-200.
DR   PDB; 4A9J; X-ray; 1.90 A; A/B/C=67-200.
DR   PDB; 4A9M; X-ray; 2.06 A; A/B/C=67-200.
DR   PDB; 4A9N; X-ray; 1.85 A; A/B/C=67-200.
DR   PDB; 4A9O; X-ray; 1.78 A; A/B/C=67-200.
DR   PDB; 4AKN; X-ray; 1.82 A; A/B/C=67-200.
DR   PDB; 4ALG; X-ray; 1.60 A; A=67-200.
DR   PDB; 4ALH; X-ray; 1.78 A; A/B/C=67-200.
DR   PDB; 4J1P; X-ray; 1.08 A; A=344-455.
DR   PDB; 4MR5; X-ray; 1.63 A; A=344-455.
DR   PDB; 4MR6; X-ray; 1.67 A; A=344-455.
DR   PDB; 4QEU; X-ray; 1.50 A; A=344-455.
DR   PDB; 4QEV; X-ray; 1.80 A; A=344-455.
DR   PDB; 4QEW; X-ray; 1.70 A; A=344-455.
DR   PDB; 4UYF; X-ray; 1.60 A; A/B/C=67-200.
DR   PDB; 4UYG; X-ray; 2.50 A; A/B/C/D/E/F=338-473.
DR   PDB; 4UYH; X-ray; 1.73 A; A/B/C=67-200.
DR   PDB; 5BT5; X-ray; 1.40 A; A=344-455.
DR   PDB; 5DFB; X-ray; 1.40 A; A=344-455.
DR   PDB; 5DFC; X-ray; 1.50 A; A=344-455.
DR   PDB; 5DFD; X-ray; 1.50 A; A=344-455.
DR   PDB; 5DW1; X-ray; 1.55 A; A/B/C/D=345-455.
DR   PDB; 5EK9; X-ray; 2.08 A; A/B=344-455.
DR   PDB; 5HEL; X-ray; 1.45 A; A=71-194.
DR   PDB; 5HEM; X-ray; 1.65 A; A/B=71-194.
DR   PDB; 5HEN; X-ray; 1.79 A; A/B/C=71-194.
DR   PDB; 5HFQ; X-ray; 1.40 A; A=344-455.
DR   PDB; 5IBN; X-ray; 0.94 A; A=348-455.
DR   PDB; 5IG6; X-ray; 0.91 A; A=348-454.
DR   PDB; 5N2L; X-ray; 1.89 A; A/B/C/D=344-455.
DR   PDB; 5O38; X-ray; 1.20 A; A=344-455.
DR   PDB; 5O39; X-ray; 1.74 A; A=344-455.
DR   PDB; 5O3A; X-ray; 2.40 A; A=344-455.
DR   PDB; 5O3B; X-ray; 1.95 A; A/B/C/D=344-455.
DR   PDB; 5O3C; X-ray; 1.60 A; A=344-455.
DR   PDB; 5O3D; X-ray; 1.60 A; A=345-455.
DR   PDB; 5O3E; X-ray; 1.40 A; A=344-455.
DR   PDB; 5O3F; X-ray; 1.75 A; A=344-455.
DR   PDB; 5O3G; X-ray; 1.85 A; A/B=344-455.
DR   PDB; 5O3H; X-ray; 1.40 A; A=344-455.
DR   PDB; 5O3I; X-ray; 1.20 A; A=344-455.
DR   PDB; 5U5S; NMR; -; A=344-455.
DR   PDB; 5U6V; X-ray; 1.77 A; A=347-455.
DR   PDB; 5UEW; X-ray; 1.83 A; A/B=347-454.
DR   PDB; 5XHE; X-ray; 1.40 A; A=348-455.
DR   PDB; 5XHK; X-ray; 1.28 A; A=348-455.
DR   PDB; 6CUI; NMR; -; A=621-750.
DR   PDB; 6DB0; X-ray; 1.70 A; A/B/C=67-200.
DR   PDB; 6DBC; X-ray; 1.05 A; A=348-455.
DR   PDB; 6DDI; X-ray; 1.50 A; A/B/C=67-200.
DR   PDB; 6DDJ; X-ray; 1.05 A; A=348-455.
DR   PDB; 6E6J; X-ray; 2.44 A; A/B/C/D/E/F=348-455.
DR   PDB; 6FFE; X-ray; 1.76 A; A=344-455.
DR   PDB; 6FFF; X-ray; 1.67 A; A=344-455.
DR   PDB; 6FFG; X-ray; 1.59 A; A=344-455.
DR   PDB; 6I80; X-ray; 1.14 A; A/B=348-455.
DR   PDB; 6I81; X-ray; 1.74 A; A=348-455.
DR   PDB; 6JKE; X-ray; 1.50 A; A/B/C=73-194.
DR   PDB; 6K04; X-ray; 1.25 A; A=344-455.
DR   PDB; 6K05; X-ray; 1.94 A; A/B/C=73-194.
DR   PDB; 6MO7; X-ray; 1.85 A; A/B/C=71-194.
DR   PDB; 6MO8; X-ray; 1.80 A; A/B/C=71-194.
DR   PDB; 6MO9; X-ray; 1.80 A; A/B/C=71-194.
DR   PDB; 6MOA; X-ray; 1.27 A; A=346-455.
DR   PDB; 6ONY; X-ray; 1.98 A; A/B=73-194.
DR   PDB; 6SWO; X-ray; 1.60 A; AAA=344-455.
DR   PDB; 6SWP; X-ray; 1.60 A; AAA=344-455.
DR   PDB; 6TQ1; X-ray; 1.90 A; AAA/BBB/CCC=67-200.
DR   PDB; 6TQ2; X-ray; 2.26 A; AAA/BBB/CCC=67-200.
DR   PDB; 6U61; X-ray; 2.29 A; A/B=65-194.
DR   PDB; 6U71; X-ray; 1.47 A; A=347-455.
DR   PDB; 6U8H; X-ray; 2.07 A; A=65-194.
DR   PDB; 6ULQ; X-ray; 2.70 A; A/B/C=65-194.
DR   PDB; 6ULT; X-ray; 2.80 A; A/B/C/D/E/F/G/H=347-454.
DR   PDB; 6VIY; X-ray; 1.90 A; A/B=348-455.
DR   PDB; 6WWB; X-ray; 1.31 A; A=348-455.
DR   PDB; 6YTM; X-ray; 1.56 A; A/B=345-455.
DR   PDB; 6Z7F; X-ray; 1.60 A; AAA=344-455.
DR   PDB; 6Z8P; X-ray; 1.55 A; AAA=344-455.
DR   PDB; 6ZB0; X-ray; 1.61 A; AAA=344-455.
DR   PDB; 6ZB1; X-ray; 1.60 A; AAA=344-455.
DR   PDB; 6ZB2; X-ray; 2.28 A; AAA=344-455.
DR   PDB; 7DPN; X-ray; 1.80 A; A/B/C=73-194.
DR   PDB; 7DPO; X-ray; 2.30 A; A=348-455.
DR   PDB; 7ENV; X-ray; 2.45 A; A/B/C=73-194.
DR   PDB; 7ENZ; X-ray; 1.70 A; A=348-455.
DR   PDB; 7EO5; X-ray; 2.00 A; A=348-455.
DR   PDB; 7JX7; X-ray; 1.75 A; A=347-455.
DR   PDB; 7L6D; X-ray; 1.55 A; A=344-455.
DR   PDB; 7L9G; X-ray; 1.36 A; A=344-455.
DR   PDB; 7L9J; X-ray; 1.85 A; A=344-455.
DR   PDB; 7L9K; X-ray; 1.95 A; A/B=344-455.
DR   PDB; 7LAK; X-ray; 1.83 A; A=73-194.
DR   PDB; 7NPY; X-ray; 1.60 A; AAA=344-455.
DR   PDB; 7NPZ; X-ray; 1.28 A; AAA=344-455.
DR   PDB; 7NQ0; X-ray; 1.30 A; AAA=344-455.
DR   PDB; 7NQ1; X-ray; 1.60 A; AAA=344-455.
DR   PDB; 7NQ2; X-ray; 1.74 A; AAA=344-455.
DR   PDB; 7NQ3; X-ray; 1.60 A; AAA=344-455.
DR   PDB; 7NQ5; X-ray; 1.60 A; AAA=344-455.
DR   PDB; 7NQ7; X-ray; 1.70 A; AAA=344-455.
DR   PDB; 7NQ8; X-ray; 1.60 A; A=344-455.
DR   PDB; 7NQ9; X-ray; 1.60 A; AAA=344-455.
DR   PDB; 7NQI; X-ray; 1.60 A; A=344-455.
DR   PDB; 7NQJ; X-ray; 1.73 A; A=344-455.
DR   PDB; 7OE4; X-ray; 1.65 A; AAA=344-455.
DR   PDB; 7OE5; X-ray; 1.60 A; AAA=344-455.
DR   PDB; 7OE6; X-ray; 1.76 A; AAA=344-455.
DR   PDB; 7OE8; X-ray; 1.30 A; A=344-455.
DR   PDB; 7OE9; X-ray; 1.60 A; A=344-455.
DR   PDB; 7OEP; X-ray; 1.80 A; AAA=344-455.
DR   PDB; 7OER; X-ray; 1.60 A; AAA=344-455.
DR   PDB; 7OES; X-ray; 1.60 A; AAA=344-455.
DR   PDB; 7OET; X-ray; 1.41 A; AAA=344-455.
DR   PDB; 7OGY; X-ray; 1.60 A; AAA=344-455.
DR   PDBsum; 1X0J; -.
DR   PDBsum; 2DVQ; -.
DR   PDBsum; 2DVR; -.
DR   PDBsum; 2DVS; -.
DR   PDBsum; 2DVV; -.
DR   PDBsum; 2E3K; -.
DR   PDBsum; 2G4A; -.
DR   PDBsum; 2YDW; -.
DR   PDBsum; 2YEK; -.
DR   PDBsum; 3AQA; -.
DR   PDBsum; 3ONI; -.
DR   PDBsum; 4A9E; -.
DR   PDBsum; 4A9F; -.
DR   PDBsum; 4A9H; -.
DR   PDBsum; 4A9I; -.
DR   PDBsum; 4A9J; -.
DR   PDBsum; 4A9M; -.
DR   PDBsum; 4A9N; -.
DR   PDBsum; 4A9O; -.
DR   PDBsum; 4AKN; -.
DR   PDBsum; 4ALG; -.
DR   PDBsum; 4ALH; -.
DR   PDBsum; 4J1P; -.
DR   PDBsum; 4MR5; -.
DR   PDBsum; 4MR6; -.
DR   PDBsum; 4QEU; -.
DR   PDBsum; 4QEV; -.
DR   PDBsum; 4QEW; -.
DR   PDBsum; 4UYF; -.
DR   PDBsum; 4UYG; -.
DR   PDBsum; 4UYH; -.
DR   PDBsum; 5BT5; -.
DR   PDBsum; 5DFB; -.
DR   PDBsum; 5DFC; -.
DR   PDBsum; 5DFD; -.
DR   PDBsum; 5DW1; -.
DR   PDBsum; 5EK9; -.
DR   PDBsum; 5HEL; -.
DR   PDBsum; 5HEM; -.
DR   PDBsum; 5HEN; -.
DR   PDBsum; 5HFQ; -.
DR   PDBsum; 5IBN; -.
DR   PDBsum; 5IG6; -.
DR   PDBsum; 5N2L; -.
DR   PDBsum; 5O38; -.
DR   PDBsum; 5O39; -.
DR   PDBsum; 5O3A; -.
DR   PDBsum; 5O3B; -.
DR   PDBsum; 5O3C; -.
DR   PDBsum; 5O3D; -.
DR   PDBsum; 5O3E; -.
DR   PDBsum; 5O3F; -.
DR   PDBsum; 5O3G; -.
DR   PDBsum; 5O3H; -.
DR   PDBsum; 5O3I; -.
DR   PDBsum; 5U5S; -.
DR   PDBsum; 5U6V; -.
DR   PDBsum; 5UEW; -.
DR   PDBsum; 5XHE; -.
DR   PDBsum; 5XHK; -.
DR   PDBsum; 6CUI; -.
DR   PDBsum; 6DB0; -.
DR   PDBsum; 6DBC; -.
DR   PDBsum; 6DDI; -.
DR   PDBsum; 6DDJ; -.
DR   PDBsum; 6E6J; -.
DR   PDBsum; 6FFE; -.
DR   PDBsum; 6FFF; -.
DR   PDBsum; 6FFG; -.
DR   PDBsum; 6I80; -.
DR   PDBsum; 6I81; -.
DR   PDBsum; 6JKE; -.
DR   PDBsum; 6K04; -.
DR   PDBsum; 6K05; -.
DR   PDBsum; 6MO7; -.
DR   PDBsum; 6MO8; -.
DR   PDBsum; 6MO9; -.
DR   PDBsum; 6MOA; -.
DR   PDBsum; 6ONY; -.
DR   PDBsum; 6SWO; -.
DR   PDBsum; 6SWP; -.
DR   PDBsum; 6TQ1; -.
DR   PDBsum; 6TQ2; -.
DR   PDBsum; 6U61; -.
DR   PDBsum; 6U71; -.
DR   PDBsum; 6U8H; -.
DR   PDBsum; 6ULQ; -.
DR   PDBsum; 6ULT; -.
DR   PDBsum; 6VIY; -.
DR   PDBsum; 6WWB; -.
DR   PDBsum; 6YTM; -.
DR   PDBsum; 6Z7F; -.
DR   PDBsum; 6Z8P; -.
DR   PDBsum; 6ZB0; -.
DR   PDBsum; 6ZB1; -.
DR   PDBsum; 6ZB2; -.
DR   PDBsum; 7DPN; -.
DR   PDBsum; 7DPO; -.
DR   PDBsum; 7ENV; -.
DR   PDBsum; 7ENZ; -.
DR   PDBsum; 7EO5; -.
DR   PDBsum; 7JX7; -.
DR   PDBsum; 7L6D; -.
DR   PDBsum; 7L9G; -.
DR   PDBsum; 7L9J; -.
DR   PDBsum; 7L9K; -.
DR   PDBsum; 7LAK; -.
DR   PDBsum; 7NPY; -.
DR   PDBsum; 7NPZ; -.
DR   PDBsum; 7NQ0; -.
DR   PDBsum; 7NQ1; -.
DR   PDBsum; 7NQ2; -.
DR   PDBsum; 7NQ3; -.
DR   PDBsum; 7NQ5; -.
DR   PDBsum; 7NQ7; -.
DR   PDBsum; 7NQ8; -.
DR   PDBsum; 7NQ9; -.
DR   PDBsum; 7NQI; -.
DR   PDBsum; 7NQJ; -.
DR   PDBsum; 7OE4; -.
DR   PDBsum; 7OE5; -.
DR   PDBsum; 7OE6; -.
DR   PDBsum; 7OE8; -.
DR   PDBsum; 7OE9; -.
DR   PDBsum; 7OEP; -.
DR   PDBsum; 7OER; -.
DR   PDBsum; 7OES; -.
DR   PDBsum; 7OET; -.
DR   PDBsum; 7OGY; -.
DR   AlphaFoldDB; P25440; -.
DR   SASBDB; P25440; -.
DR   SMR; P25440; -.
DR   BioGRID; 111973; 386.
DR   DIP; DIP-60835N; -.
DR   IntAct; P25440; 45.
DR   MINT; P25440; -.
DR   STRING; 9606.ENSP00000378704; -.
DR   BindingDB; P25440; -.
DR   ChEMBL; CHEMBL1293289; -.
DR   GuidetoPHARMACOLOGY; 1944; -.
DR   GlyGen; P25440; 6 sites, 2 O-linked glycans (6 sites).
DR   iPTMnet; P25440; -.
DR   PhosphoSitePlus; P25440; -.
DR   BioMuta; BRD2; -.
DR   DMDM; 12230989; -.
DR   CPTAC; CPTAC-1598; -.
DR   EPD; P25440; -.
DR   jPOST; P25440; -.
DR   MassIVE; P25440; -.
DR   MaxQB; P25440; -.
DR   PaxDb; P25440; -.
DR   PeptideAtlas; P25440; -.
DR   PRIDE; P25440; -.
DR   ProteomicsDB; 54271; -. [P25440-1]
DR   ProteomicsDB; 54272; -. [P25440-2]
DR   ProteomicsDB; 65931; -.
DR   ABCD; P25440; 1 sequenced antibody.
DR   Antibodypedia; 28816; 400 antibodies from 38 providers.
DR   DNASU; 6046; -.
DR   Ensembl; ENST00000374825.9; ENSP00000363958.4; ENSG00000204256.14. [P25440-1]
DR   Ensembl; ENST00000374831.8; ENSP00000363964.4; ENSG00000204256.14. [P25440-1]
DR   Ensembl; ENST00000383108.6; ENSP00000372588.2; ENSG00000234507.9. [P25440-1]
DR   Ensembl; ENST00000395287.5; ENSP00000378702.1; ENSG00000204256.14. [P25440-2]
DR   Ensembl; ENST00000399527.5; ENSP00000382443.1; ENSG00000215077.10. [P25440-2]
DR   Ensembl; ENST00000399528.5; ENSP00000382444.1; ENSG00000215077.10. [P25440-1]
DR   Ensembl; ENST00000399529.7; ENSP00000382445.3; ENSG00000215077.10. [P25440-1]
DR   Ensembl; ENST00000414731.6; ENSP00000391246.2; ENSG00000234704.9.
DR   Ensembl; ENST00000436979.5; ENSP00000405634.1; ENSG00000235307.12. [P25440-3]
DR   Ensembl; ENST00000438194.6; ENSP00000401791.2; ENSG00000234507.9. [P25440-1]
DR   Ensembl; ENST00000442863.5; ENSP00000410994.1; ENSG00000234507.9. [P25440-2]
DR   Ensembl; ENST00000448067.5; ENSP00000412885.1; ENSG00000235307.12. [P25440-2]
DR   Ensembl; ENST00000449085.4; ENSP00000409145.3; ENSG00000204256.14. [P25440-1]
DR   Ensembl; ENST00000449118.5; ENSP00000399009.1; ENSG00000234704.9.
DR   Ensembl; ENST00000549126.4; ENSP00000449380.2; ENSG00000235307.12. [P25440-1]
DR   Ensembl; ENST00000552587.4; ENSP00000449609.1; ENSG00000235307.12. [P25440-1]
DR   Ensembl; ENST00000678250.1; ENSP00000502900.1; ENSG00000204256.14. [P25440-1]
DR   GeneID; 6046; -.
DR   KEGG; hsa:6046; -.
DR   MANE-Select; ENST00000374825.9; ENSP00000363958.4; NM_005104.4; NP_005095.1.
DR   UCSC; uc003ocn.4; human. [P25440-1]
DR   CTD; 6046; -.
DR   DisGeNET; 6046; -.
DR   GeneCards; BRD2; -.
DR   HGNC; HGNC:1103; BRD2.
DR   HPA; ENSG00000204256; Low tissue specificity.
DR   MIM; 601540; gene.
DR   neXtProt; NX_P25440; -.
DR   OpenTargets; ENSG00000204256; -.
DR   PharmGKB; PA25414; -.
DR   VEuPathDB; HostDB:ENSG00000204256; -.
DR   eggNOG; KOG1474; Eukaryota.
DR   GeneTree; ENSGT00940000153385; -.
DR   HOGENOM; CLU_001499_0_4_1; -.
DR   InParanoid; P25440; -.
DR   OMA; MNIPHYP; -.
DR   OrthoDB; 619848at2759; -.
DR   PhylomeDB; P25440; -.
DR   TreeFam; TF317345; -.
DR   PathwayCommons; P25440; -.
DR   Reactome; R-HSA-8951936; RUNX3 regulates p14-ARF.
DR   SignaLink; P25440; -.
DR   SIGNOR; P25440; -.
DR   BioGRID-ORCS; 6046; 284 hits in 1124 CRISPR screens.
DR   ChiTaRS; BRD2; human.
DR   EvolutionaryTrace; P25440; -.
DR   GeneWiki; BRD2; -.
DR   GenomeRNAi; 6046; -.
DR   Pharos; P25440; Tchem.
DR   PRO; PR:P25440; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P25440; protein.
DR   Bgee; ENSG00000204256; Expressed in ventricular zone and 96 other tissues.
DR   ExpressionAtlas; P25440; baseline and differential.
DR   Genevisible; P25440; HS.
DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:FlyBase.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0070577; F:lysine-acetylated histone binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:FlyBase.
DR   GO; GO:0006338; P:chromatin remodeling; IBA:GO_Central.
DR   GO; GO:0001843; P:neural tube closure; IEA:Ensembl.
DR   GO; GO:0006334; P:nucleosome assembly; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:FlyBase.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; TAS:ProtInc.
DR   CDD; cd05497; Bromo_Brdt_I_like; 1.
DR   CDD; cd05498; Bromo_Brdt_II_like; 1.
DR   Gene3D; 1.20.1270.220; -; 1.
DR   Gene3D; 1.20.920.10; -; 2.
DR   InterPro; IPR043508; Bromo_Brdt_I.
DR   InterPro; IPR043509; Bromo_Brdt_II.
DR   InterPro; IPR001487; Bromodomain.
DR   InterPro; IPR036427; Bromodomain-like_sf.
DR   InterPro; IPR018359; Bromodomain_CS.
DR   InterPro; IPR027353; NET_dom.
DR   InterPro; IPR038336; NET_sf.
DR   Pfam; PF17035; BET; 1.
DR   Pfam; PF00439; Bromodomain; 2.
DR   PRINTS; PR00503; BROMODOMAIN.
DR   SMART; SM00297; BROMO; 2.
DR   SUPFAM; SSF47370; SSF47370; 2.
DR   PROSITE; PS00633; BROMODOMAIN_1; 2.
DR   PROSITE; PS50014; BROMODOMAIN_2; 2.
DR   PROSITE; PS51525; NET; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Bromodomain;
KW   Chromatin regulator; Host-virus interaction; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Transcription; Transcription regulation.
FT   CHAIN           1..801
FT                   /note="Bromodomain-containing protein 2"
FT                   /id="PRO_0000211180"
FT   DOMAIN          91..163
FT                   /note="Bromo 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00035"
FT   DOMAIN          364..436
FT                   /note="Bromo 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00035"
FT   DOMAIN          632..714
FT                   /note="NET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00857"
FT   REGION          53..73
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          268..349
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          456..647
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          737..801
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           555..559
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        312..336
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        471..485
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        486..511
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        512..526
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        545..563
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        564..580
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        633..647
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        760..801
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:20068231"
FT   MOD_RES         6
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         37
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         298
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         301
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         305
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         633
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..120
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_055028"
FT   VAR_SEQ         1..47
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_055029"
FT   VAR_SEQ         615
FT                   /note="L -> LQAGVQWRDLGLLQPPLLGFKRFSCLSLPSSQDYRL (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_022600"
FT   VARIANT         30
FT                   /note="G -> E (in a glioblastoma multiforme sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041904"
FT   VARIANT         49
FT                   /note="A -> G (in dbSNP:rs3918144)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041905"
FT   VARIANT         49
FT                   /note="A -> S (in dbSNP:rs55669504)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041906"
FT   VARIANT         212
FT                   /note="A -> P (in dbSNP:rs35952031)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041907"
FT   VARIANT         238
FT                   /note="L -> F (in dbSNP:rs176250)"
FT                   /evidence="ECO:0000269|PubMed:14574404,
FT                   ECO:0000269|PubMed:17344846"
FT                   /id="VAR_022132"
FT   VARIANT         260
FT                   /note="P -> Q (in dbSNP:rs35294809)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041908"
FT   VARIANT         474
FT                   /note="A -> V (in dbSNP:rs3918143)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_029300"
FT   VARIANT         547
FT                   /note="R -> K (in dbSNP:rs1049369)"
FT                   /id="VAR_029301"
FT   VARIANT         558
FT                   /note="R -> G (in a gastric adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041909"
FT   VARIANT         569
FT                   /note="A -> T (in dbSNP:rs34530779)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041910"
FT   VARIANT         599
FT                   /note="A -> P (in dbSNP:rs55952113)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041911"
FT   VARIANT         714
FT                   /note="P -> L (in a glioblastoma multiforme sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041912"
FT   MUTAGEN         78
FT                   /note="Q->A: Loss of homodimerization."
FT                   /evidence="ECO:0000269|PubMed:17148447"
FT   MUTAGEN         142..143
FT                   /note="MQ->AA: Loss of homodimerization."
FT                   /evidence="ECO:0000269|PubMed:17148447"
FT   MUTAGEN         153
FT                   /note="Y->K: Loss of homodimerization."
FT                   /evidence="ECO:0000269|PubMed:17148447"
FT   MUTAGEN         154
FT                   /note="I->A: Partial loss of homodimerization; when
FT                   associated with A-182."
FT                   /evidence="ECO:0000269|PubMed:17148447"
FT   MUTAGEN         170
FT                   /note="E->A: Loss of homodimerization."
FT                   /evidence="ECO:0000269|PubMed:17148447"
FT   MUTAGEN         174
FT                   /note="L->E: Loss of homodimerization."
FT                   /evidence="ECO:0000269|PubMed:17148447"
FT   MUTAGEN         177
FT                   /note="V->E: Loss of homodimerization."
FT                   /evidence="ECO:0000269|PubMed:17148447"
FT   MUTAGEN         182
FT                   /note="Q->A: Partial loss of homodimerization; when
FT                   associated with A-154."
FT                   /evidence="ECO:0000269|PubMed:17148447"
FT   CONFLICT        490
FT                   /note="S -> F (in Ref. 4; CAH56179)"
FT                   /evidence="ECO:0000305"
FT   HELIX           77..84
FT                   /evidence="ECO:0007829|PDB:5HEL"
FT   HELIX           86..91
FT                   /evidence="ECO:0007829|PDB:5HEL"
FT   HELIX           97..99
FT                   /evidence="ECO:0007829|PDB:5HEL"
FT   HELIX           105..108
FT                   /evidence="ECO:0007829|PDB:5HEL"
FT   HELIX           113..116
FT                   /evidence="ECO:0007829|PDB:5HEL"
FT   HELIX           123..131
FT                   /evidence="ECO:0007829|PDB:5HEL"
FT   HELIX           138..155
FT                   /evidence="ECO:0007829|PDB:5HEL"
FT   HELIX           161..177
FT                   /evidence="ECO:0007829|PDB:5HEL"
FT   STRAND          186..189
FT                   /evidence="ECO:0007829|PDB:6ULQ"
FT   HELIX           348..360
FT                   /evidence="ECO:0007829|PDB:5IG6"
FT   HELIX           363..365
FT                   /evidence="ECO:0007829|PDB:5IG6"
FT   HELIX           366..369
FT                   /evidence="ECO:0007829|PDB:5IG6"
FT   HELIX           370..372
FT                   /evidence="ECO:0007829|PDB:5IG6"
FT   HELIX           378..381
FT                   /evidence="ECO:0007829|PDB:5IG6"
FT   HELIX           386..389
FT                   /evidence="ECO:0007829|PDB:5IG6"
FT   HELIX           396..404
FT                   /evidence="ECO:0007829|PDB:5IG6"
FT   TURN            406..408
FT                   /evidence="ECO:0007829|PDB:2G4A"
FT   HELIX           411..428
FT                   /evidence="ECO:0007829|PDB:5IG6"
FT   STRAND          431..433
FT                   /evidence="ECO:0007829|PDB:5U5S"
FT   HELIX           434..450
FT                   /evidence="ECO:0007829|PDB:5IG6"
FT   STRAND          628..631
FT                   /evidence="ECO:0007829|PDB:6CUI"
FT   TURN            634..638
FT                   /evidence="ECO:0007829|PDB:6CUI"
FT   HELIX           644..654
FT                   /evidence="ECO:0007829|PDB:6CUI"
FT   HELIX           659..670
FT                   /evidence="ECO:0007829|PDB:6CUI"
FT   TURN            674..678
FT                   /evidence="ECO:0007829|PDB:6CUI"
FT   STRAND          681..683
FT                   /evidence="ECO:0007829|PDB:6CUI"
FT   TURN            688..690
FT                   /evidence="ECO:0007829|PDB:6CUI"
FT   HELIX           693..707
FT                   /evidence="ECO:0007829|PDB:6CUI"
FT   HELIX           725..743
FT                   /evidence="ECO:0007829|PDB:6CUI"
SQ   SEQUENCE   801 AA;  88061 MW;  9A075EEB13507D8E CRC64;
     MLQNVTPHNK LPGEGNAGLL GLGPEAAAPG KRIRKPSLLY EGFESPTMAS VPALQLTPAN
     PPPPEVSNPK KPGRVTNQLQ YLHKVVMKAL WKHQFAWPFR QPVDAVKLGL PDYHKIIKQP
     MDMGTIKRRL ENNYYWAASE CMQDFNTMFT NCYIYNKPTD DIVLMAQTLE KIFLQKVASM
     PQEEQELVVT IPKNSHKKGA KLAALQGSVT SAHQVPAVSS VSHTALYTPP PEIPTTVLNI
     PHPSVISSPL LKSLHSAGPP LLAVTAAPPA QPLAKKKGVK RKADTTTPTP TAILAPGSPA
     SPPGSLEPKA ARLPPMRRES GRPIKPPRKD LPDSQQQHQS SKKGKLSEQL KHCNGILKEL
     LSKKHAAYAW PFYKPVDASA LGLHDYHDII KHPMDLSTVK RKMENRDYRD AQEFAADVRL
     MFSNCYKYNP PDHDVVAMAR KLQDVFEFRY AKMPDEPLEP GPLPVSTAMP PGLAKSSSES
     SSEESSSESS SEEEEEEDEE DEEEEESESS DSEEERAHRL AELQEQLRAV HEQLAALSQG
     PISKPKRKRE KKEKKKKRKA EKHRGRAGAD EDDKGPRAPR PPQPKKSKKA SGSGGGSAAL
     GPSGFGPSGG SGTKLPKKAT KTAPPALPTG YDSEEEEESR PMSYDEKRQL SLDINKLPGE
     KLGRVVHIIQ AREPSLRDSN PEEIEIDFET LKPSTLRELE RYVLSCLRKK PRKPYTIKKP
     VGKTKEELAL EKKRELEKRL QDVSGQLNST KKPPKKANEK TESSSAQQVA VSRLSASSSS
     SDSSSSSSSS SSSDTSDSDS G
//
